{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:36Z","timestamp":1774538676771,"version":"3.50.1"},"reference-count":68,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001125","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:31:33Z","timestamp":1069367493000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cyproterone acetate for hirsutism"],"prefix":"10.1002","volume":"2010","author":[{"given":"Zephne M","family":"van der Spuy","sequence":"first","affiliation":[{"name":"Groote Schuur Hospital; Department of Obstetrics and Gynaecology, University of Cape Town Medical School; H Floor, Old Main Building Observatory Cape Town South Africa 7925"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Andre","family":"Le Roux","sequence":"additional","affiliation":[{"name":"Cape Fertility Clinic; Department of Obstetrics and Gynaecology; 209 Library Square Claremont Cape Town South Africa 7708"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushi J","family":"Matjila","sequence":"additional","affiliation":[{"name":"Groote Schuur Hospital; Private Bag Observatory7937 Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,20]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jcem-63-4-1031","article-title":"Comparative effects of cyproterone acetate or a long acting gonadotrophin releasing hormone agonist in polycystic ovary disease","volume":"63","author":"Couzinet","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/01443619109013510","article-title":"Hirsutography: photographic measurement of linear hair growth in hirsute women during comparison of anti-androgen treatments","volume":"11","author":"Dixon","year":"1991","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0015-0282(16)58441-6","article-title":"Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism","volume":"22","author":"Erenus","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001125-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(98)00486-5","article-title":"Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects","volume":"71","author":"Fruzetti","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09513599609012316","article-title":"Comparison of four different treatment regimens in hirsutism related to polycystic ovary syndrome","volume":"10","author":"Gokmen","year":"1996","journal-title":"Gynaecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09513599609097901","article-title":"Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomised controlled trial","volume":"10","author":"Grigoriou","year":"1996","journal-title":"Gynaecological Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD001125-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-72-5-1008","article-title":"Comparison of sequential cyproterone acetate\/estrogen versus spironolactone \/oral contraceptive in the treatment of hirsutism","volume":"72","author":"O'Brien","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0015-0282(98)00414-2","article-title":"Prospective randomised study comparing the long-acting gonadotrophin-releasing hormone agonist triptorelin, flutamide and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism","volume":"71","author":"Pazos","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0009|cit9","first-page":"109","article-title":"Treatment of hirustism in polycystic ovary syndrome with Diane, 50 mcg ethinyl estradiol and 2mg cyproterone acetate","volume":"9","author":"Saeed","year":"1993","journal-title":"Pakistan Journal of Medical Science"},{"issue":"5","key":"10.1002\/14651858.CD001125-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01542482","article-title":"Effects of anti-androgen estrogen treatment on sexual and endocrine parameters in hirsute women","volume":"17","author":"Adamopoulos","year":"1988","journal-title":"Archives of Sexual Behaviour"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2265.1991.tb03489.x","article-title":"Cyproterone acetate for severe hirsutism: results of a double blind dose-ranging study","volume":"35","author":"Barth","year":"1991","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0015-0282(16)49873-0","article-title":"Clinical efficacy and safety of cyproterone acetate in severe hirsutism : results of a multicentered Canadian study","volume":"46","author":"Belisle","year":"1986","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000017849","article-title":"Oral contraceptives and cyproterone acetate in female acne treatment","volume":"196","author":"Beylot","year":"1998","journal-title":"Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0015-0282(98)00061-2","article-title":"The addition of dexamethazone to antiandrogen therapy for hirsutism prolongs the duration of remission","volume":"69","author":"Carmina","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13625189809051408","article-title":"Effects of bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a two year follow-up","volume":"3","author":"Castelo-Branco","year":"1998","journal-title":"The European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception"},{"issue":"12","key":"10.1002\/14651858.CD001125-BIB0016|cit16","first-page":"783","article-title":"Acceptance, tolerance and effects on quality of life of treatment of hiruste women with cyproterone acetate. Comparison of associated treatment with oral estradiol to transdermal estradiol","volume":"22","author":"Consoli","year":"1994","journal-title":"Contraception, Fertilite, Sexualite"},{"key":"10.1002\/14651858.CD001125-BIB0017|cit17","unstructured":"Cremoncini C Vignati E Libroia A Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol International Symposium on Androgens and Anti-androgens 1976 300 13"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00016349009021041","article-title":"Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms","volume":"69","author":"Erkkola","year":"1990","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD001125-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01660957","article-title":"Therapy for women with hirsutism with adrenal enzyme defects of enzyme biosynthesis: compared with dexamethazone compbined with cyproterone acetate","volume":"68","author":"Frank-Raue","year":"1990","journal-title":"Klinische Wochenschrift"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.134.4.459","article-title":"Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial","volume":"134","author":"Gruber","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"48","key":"10.1002\/14651858.CD001125-BIB0021|cit21","first-page":"2180","article-title":"The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate)","volume":"26","author":"Grund","year":"1975","journal-title":"Die Medizinische Welt"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0022|cit22","first-page":"522","article-title":"Cyproterone acetate as intial treatment and maintenance therapy for hirsutism","volume":"109","author":"Holdaway","year":"1985","journal-title":"Acta Endocrinologica"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0015-0282(16)54240-X","article-title":"Treatment of hirustism by an association of oral cyproterone acetate and transdermal 17 beta estradiol","volume":"55","author":"Jasonni","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0015-0282(97)00427-5","article-title":"Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism","volume":"69","author":"Kelestimur","year":"1997","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001125-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jcem-51-5-1107","article-title":"Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol","volume":"51","author":"Kuttenn","year":"1980","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"45","key":"10.1002\/14651858.CD001125-BIB0026|cit26","first-page":"1922","article-title":"Therapy of androgenisation symptoms","volume":"72","author":"Lachnit-Fixson","year":"1977","journal-title":"Medizinische Klinik"},{"issue":"Suppl","key":"10.1002\/14651858.CD001125-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00016347909157227","article-title":"The development and evaluation of an ovulation inhibitor (Diane) containing an antiandrogen","volume":"88","author":"Lachnit-Fixson","year":"1979","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0015-0282(16)53213-0","article-title":"Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects","volume":"53","author":"Marcondes","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2008-1036425","article-title":"Medium dose cyproterone acetate therapy for women with moderate hyperandrogenism","volume":"44","author":"Moltz","year":"1984","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9378(86)90410-2","article-title":"Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries","volume":"154","author":"Pasquali","year":"1986","journal-title":"American Journal of Obstetrics and Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD001125-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0015-0282(16)54291-5","article-title":"Long term treatment of hirustism: desogestrel compared with cyproterone acetate in oral contraceptives","volume":"55","author":"Porcile","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/09513599709152569","article-title":"Treatment of androgen excess in females: yesterday, today and tomorrow","volume":"11","author":"Pucci","year":"1997","journal-title":"Gynaecological Endocrinology"},{"key":"10.1002\/14651858.CD001125-BIB0033|cit33","first-page":"1057","article-title":"Administration of cyproterone acetate and natural estrogens in the treatment of hirustism","volume":"20","author":"Pugeat","year":"1991","journal-title":"Journal of Obstetrics and Gynaecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001125-BIB0034|cit34","first-page":"387","article-title":"Action mechanisms of cyproterone acetate in the treatment of hirustism","volume":"44","author":"Rigaud","year":"1983","journal-title":"Annals of Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0889-8529(05)70077-3","article-title":"Antiandrogen treatment of polycystic ovary syndrome","volume":"28","author":"Rittmaster","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350769","article-title":"Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism","volume":"21","author":"Sahin","year":"1998","journal-title":"Journal of Endocrinological Investigation"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000298791","article-title":"Parenteral and oral cyproterone acetate treatment in severe hirsutism","volume":"24","author":"Schmidt","year":"1987","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"19","key":"10.1002\/14651858.CD001125-BIB0039|cit39","first-page":"20","article-title":"The treatment of hirustism: experience with cyproterone acetate and spironolactone","volume":"26","author":"Thomas","year":"1985","journal-title":"Australian Journal of Dermatology"},{"key":"10.1002\/14651858.CD001125-BIB0040|cit40","doi-asserted-by":"crossref","unstructured":"van der Spuy ZM Nugent FA The managment of hirustism in PCOS using GnRH agonist analogue therapy Abstract - 27th British Congress of Obstetrics and Gynaecology 1995","DOI":"10.1111\/j.1471-0528.1995.tb10917.x"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000292281","article-title":"An open randomised comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long term treatment of hirsutism","volume":"41","author":"Vegetti","year":"1996","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","article-title":"A prospective randomised trial comparing low dose flutamide, finasteride, ketoconazole and cyproterone acetate-estrogen regimens in the treatment of hirustism","volume":"84","author":"Venturoli","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(88)90083-2","article-title":"Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women","volume":"38","author":"Vermeulen","year":"1988","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD001125-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0015-0282(16)57418-4","article-title":"17 beta estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate","volume":"63","author":"Vexiau","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001125-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1440-0960.1998.tb01271.x","article-title":"Hirsutes II: treatment","volume":"39","author":"Young","year":"1998","journal-title":"Australian Journal of Dermatology"},{"issue":"6543","key":"10.1002\/14651858.CD001125-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"British Medical Journal Clinical Research Edition"},{"issue":"1-4","key":"10.1002\/14651858.CD001125-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000287842","article-title":"Effects of anti-androgen treatment on the sexuality of women with hyperandrogenism","volume":"42","author":"Appelt","year":"1984","journal-title":"Psychotherapy and psychosomatics"},{"key":"10.1002\/14651858.CD001125-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/9783110866902-013","article-title":"Antiandrogen treatment in women with acne: a controlled trial","volume-title":"Antiandrogen-estrogen therapy for signs of androgenisation","author":"Ashton","year":"1987"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1989.tb08208.x","article-title":"Most women with acne have polycystic ovaries","volume":"121","author":"Bunker","year":"1989","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD001125-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD001125-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem-32-6-737","article-title":"Androgen metabolism in human skin","volume":"32","author":"Flamigni","year":"1971","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic ovary syndrome: a changing perspective","volume":"31","author":"Franks","year":"1989","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0022-4731(75)90311-8","article-title":"Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism","volume":"6","author":"Hammerstein","year":"1975","journal-title":"Journal of Steroid Biochemistry"},{"issue":"1B","key":"10.1002\/14651858.CD001125-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0022-4731(83)90223-6","article-title":"Antiandrogens in the treatment of acne and hirsutism","volume":"19","author":"Hammerstein","year":"1983","journal-title":"Journal of Steroid Biochemistry"},{"issue":"6","key":"10.1002\/14651858.CD001125-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2133.1981.tb00979.x","article-title":"Effect of cyproterone acetate on rate of hair growth in hirsute women","volume":"105","author":"Jones","year":"1981","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD001125-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jcem-51-5-1107","article-title":"Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol","volume":"51","author":"Kuttenn","year":"1980","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125-BIB0058|cit58","first-page":"91","article-title":"The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women","volume":"100","author":"Lunnell","year":"1982","journal-title":"Acta Endocrinology"},{"key":"10.1002\/14651858.CD001125-BIB0059|cit59","first-page":"177","article-title":"The prevalence of \"hirsutism\" in young women","volume":"42","author":"McKnight","year":"1964","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-52-2-338","article-title":"Androgen receptor in human skin cytosol","volume":"52","author":"Mowszowicz","year":"1981","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-56-2-320","article-title":"Dihydrotestosterone stimulates 5-alpha reductase activity in pubic skin fibroblasts","volume":"56","author":"Mowszowicz","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001125-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/9783110866902-004","article-title":"Pharmacological aspects of cyproterone acetate","volume-title":"Anti-androgen estrogen therapy for signs of androgenisation","author":"Neumann","year":"1987"},{"key":"10.1002\/14651858.CD001125-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1515\/9783110866902-022","article-title":"Comparison of Diane 35 with Neo-Eunomin from the dermatological viewpoint","volume-title":"Anti-androgen estrogen therapy for signs of androgenisation","author":"Nurnberger","year":"1987"},{"issue":"3","key":"10.1002\/14651858.CD001125-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0950-3552(88)80045-2","article-title":"Anti-androgens in gynaecological practice","volume":"2","author":"Reed","year":"1988","journal-title":"Baillieres Clinical Obstetrics & Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD001125-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2265.1984.tb00088.x","article-title":"Androgen levels during cyproterone acetate in ethinyl estradiol treatment of hirsutism","volume":"20","author":"Rubens","year":"1984","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD001125-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1523-1747.ep12551679","article-title":"Human hair cycle","volume":"54","author":"Saitoh","year":"1970","journal-title":"Journal of Dermatology Investigation"},{"issue":"1","key":"10.1002\/14651858.CD001125-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2133.1985.tb02038.x","article-title":"The hair cycle on the human thigh and upper arm","volume":"113","author":"Seago","year":"1985","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD001125-BIB0068|cit68","first-page":"90","article-title":"Management of hyperandrogenism","volume":"4","author":"Spuy","year":"1992","journal-title":"Contemporary Reviews in Obstetrics and Gynaecology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001125.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001125\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:16:38Z","timestamp":1763036198000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001125"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,10,20]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001125","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,20]]}}}